When should we delay highly active antiretroviral therapy?

J Gen Intern Med. 1999 Jul;14(7):446-8. doi: 10.1046/j.1525-1497.1999.05109.x.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-HIV Agents / administration & dosage*
  • Depression / complications
  • Drug Therapy, Combination
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV-1*
  • Humans
  • Patient Compliance*
  • Substance Abuse, Intravenous / complications
  • Time Factors

Substances

  • Anti-HIV Agents